MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 6, 2013, Pages 834-839

  Zhao, Fang ^a   Li, Bo ^a   Wei, Yin Zhi ^a   Zhou, Bin ^a   Wang, Han ^a   Chen, Ming ^a   Gan, Xue Dong ^a   Wang, Zhao Hui ^b   Xiong, Shi Xi ^a  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

apoptosis; Bcl 2; high glucose; miR 34a

Indexed keywords

GLUCOSE; MICRORNA; MIRN34 MICRORNA, RAT;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; GENETICS; HEART MUSCLE CELL; METABOLISM; RAT;

ANIMALS; APOPTOSIS; CELL LINE; GLUCOSE; MICRORNAS; MYOCYTES, CARDIAC; RATS;

EID: 84891612115     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1207-7     Document Type: Article

References (31)

1. Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol, 1972,30(6):595-602
2. Fein FS. Diabetic cardiomyopathy. Diabetes Care, 1990,13(11):1169-1179 (Pubitemid 20365922)
3. Regan TJ, Ahmed S, Haider B, et al. Diabetic cardiomyopathy: experimental and clinical observations. N J Med, 1994,91(11):776-778
4. Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol, 2006,47(4):693-700 (Pubitemid 43243087)
5. Rota M, LeCapitaine N, Hosoda T, et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res, 2006,99(1):42-52 (Pubitemid 44297054)
6. Yoon YS, Uchida S, Masuo O, et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation, 2005,111(6):2073-2085 (Pubitemid 40577902)
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004,116(2):281-297 (Pubitemid 38167318)
8. Rooij EV, Sutherland L, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007,316(5824):575-579 (Pubitemid 46683138)
9. Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell, 2006,126(6):1203-1217 (Pubitemid 44380294)
10. Rooij EV, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 2006,103(48):18 255-18 260 (Pubitemid 44871645)
11. McKinsey TA, Olson EN. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest, 2005,115(3):538-546 (Pubitemid 40322223)
12. Rooij EV, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest, 2007,117(9):2369-2376 (Pubitemid 47494334)
13. Kong L, Zhu J, Han W, et al. Significance of serum mi croRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol, 2011,48(1): 61-69
14. Bertoni AG, Hundley WG, Massing MW, et al. Heart failure prevalence, incidence, and mortality in the elderly with diabetess. Diabetes Care, 2004,27:699-703 (Pubitemid 38280536)
15. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 2012,125(1): e2-220
16. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature, 200,447(7148):1130-1134
17. Dostie J, Mourelatos Z, Yang M, et al. Numerous microRNPs in neuronal cells containing novel microRNAs. RNA, 2003,9(2):180-186 (Pubitemid 36206286)
18. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol, 2002,12(9):9
19. Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun, 2010,398(4):735-740
20. Ermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ, 2010,17(2):193-199
21. Cole KA, Attiyeh EF, Mosse YP, et al. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res, 2008,6(5): 735-742
22. Lovis P, Roggli E, Laybutt DR, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes, 2008,57(10): 2728-2736
23. Baek D, Villén J, Shin C, et al. The impact of microRNAs on protein output. Nature, 2008,455(7209):64-71
24. Williams AH, Liu N, Van ER, et al. MicroRNA control of muscle development and disease. Curr Opin Cell Biol, 2009,21(3):461-469
25. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 2005,102(39):13 944-13 949 (Pubitemid 41377683)
26. Katare R, Caporali A, Zentilin L, et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res, 2011,108(10): 1238-1251
27. Reed JC, Meister L, Tanaka S, et al. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res, 1991,51(24):6529-6538
28. Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol, 2007,17(15):1298-1307 (Pubitemid 47176893)
29. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cel, 2007,26(5):745-752 (Pubitemid 46856245)
30. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle, 2009,8(5):712-715
31. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene, 2007,26(34): 5017-5022 (Pubitemid 47172643)